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This chapter complements and should be read in conjunction with 
Chapter D.1 of the IACAPAP Textbook. Attention-deficit/hyperactivity disorder 
(ADHD) is one of the most common psychiatric disorders of childhood, with 
an estimated prevalence of about 5% in school-age children. Core symptoms 
include impaired attention and/or hyperactivity/impulsivity (American Psychiatric 
Association, 2013). ADHD often has a chronic course with up to 65 % of affected 
individuals displaying impairing symptoms during adulthood (Faraone et al, 
2006). ADHD is associated with high levels of both externalizing (oppositional 
defiant disorder and conduct disorder) and internalizing (depression and anxiety) 
comorbidities. ADHD impacts on in multiple domains of functioning across the 
lifespan, including school and work performance, social relationships, and family 
interactions (Faraone et al, 2006). 
Given its impact and associated burden, considerable effort has been 
directed at developing effective treatments. Multimodal treatments, which 
combine pharmacologic and psychologic approaches, are currently recommended 
(National Institute for Health and Clinical Excellence, 2008). ADHD 
medication—i.e., stimulants (e.g., methyphenidate, d-amphetemine) and non-
stimulants (e.g., atomoxetine, guanfacine)—are effective in the short and medium 
term in randomized controlled trials in relation to core symptoms, externalizing 
comorbidities, and daily functioning (Faraone & Buitelaar, 2010; Banaschewski et 
al, 2013). Medication can also reduce neuropsychological impairment: executive 
functions, executive and non-executive memory, reaction time, reaction time 
variability, response inhibition, aversion to delayed reward, and intrinsic motivation 
(Ni et al, 2013; Coghill et al, 2013). 
Despite its proven short-term efficacy, treatment with medication has several 
limitations. These include (Sonuga-Barke et al, 2013):
• Partial or no-response in a proportion of cases
• Adverse effects
• Questionable long term benefits and costs
• Poor adherence, and 
• Negative attitudes of patients, parents, or clinicians to medication. 
Limitations of existing pharmacologic treatments highlight the need for 
therapeutic innovation to develop effective non-pharmacologic interventions 
that improve short and long term outcomes in core symptom domains, 
neuropsychological deficits and, more generally, in the pattern of impairment 
(Graham et al, 2011; Cortese et al, 2013). To date, a variety of non-pharmacological 
interventions are available to treat ADHD including psychologic treatments 
and dietary approaches. Effectiveness of some of these therapies has been partly 
supported by several systematic reviews and meta-analyses. However, some of these 
studies have significant methodological shortcomings—for example, by including 
non-randomized designs, non-ADHD samples, or non-ADHD outcomes—not 
allowing firm conclusions to be drawn (Arns et al, 2009; Fabiano et al, 2009; 
Bloch & Qawasmi, 2011; Nigg et al, 2012). 
In this chapter we describe commonly available non-pharmacologic 
approaches, their rationale, delivery, evidence of effectiveness, clinical 
considerations, and future directions for research and practice. It is important to 
note that our findings do not imply recommendation for their use.  
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EXCLUSION DIETS AND DIETARY SUPPLEMENTS
There is increasing interest in the relationship between lifestyle, diet and 
mental health. For example, a report from a prospective birth cohort study described 
a significant association between a “Western” dietary pattern—high in fat, refined 
sugars, and sodium, and low in fiber, folate, and omega-3 fatty acids—and ADHD 
(Howard et al, 2011). This section focuses on four dietary interventions—exclusion 
of artificial colors and preservatives; restrictive elimination diets/oligo-antigenic 
diets; supplementation with omega-3 fatty acids; supplementation with vitamins 
and micronutrients—and their clinical relevance for ADHD. 
ARTIFICIAL FOOD COLORS AND PRESERVATIVES
Feingold was the first to suggest that allergy to food color additives, 
synthetic flavors, and food preservatives could lead to an increase in ADHD 
symptoms (Feingold, 1985). He based this on observations that salicylates could 
not only cause asthma or eczema but also behavioral reactions, such as an increase 
of hyperkinetic behavior, in some patients. Hence, he proposed a diet free of foods 
with natural salicylates and synthetic colors and flavors. The supposed mechanism 
could be either an allergic reaction or hypersensitivity to salicylates and related 
substances.
Treatment Delivery and Available Treatments
The Feingold program is a form of elimination diet where foods containing 
certain additives are replaced with foods free of those additives. When starting 
the program, certain foods and non-food items containing aspirin-like chemicals 
called salicylates are eliminated and later tested for tolerance. These foods include: 
• Artificial colorings (e.g., petrochemical dyes) 
• Artificial flavors and fragrances 
• Some preservatives 
• Artificial sweeteners 
• And foods and products containing salicylates. 
Initially the diet is used as a  diagnostic tool to determine if any of the 
eliminated items trigger some or all of the problems observed.  When successful, it 
is continued as a treatment, and can be combined with other medical treatments. 
Effectiveness
A meta-analysis across 20 studies of elimination diets including 794 
participants found a small effect size (0.18) based on parent reports, that decreased 
to 0.12 when possible publication bias was taken into account (Nigg et al, 2012). 
Effect on teachers’ reports and observer measures was not significant (Nigg et al, 
2012). About 8% of children with ADHD were estimated to have symptoms 
related to food colors. Another meta-analysis of 8 studies including 294 participants 
reported a similar effect size (0.32 to 0.42 depending on the informant). However, 
the effect size became non-significant when the analysis was limited to studies with 
few or no concurrent medication (Sonuga-Barke et al, 2013). There are no long-
term studies.
Click on the image to view 
a very brief summary of the 
meta-analysis by Sonuga-
Barke et al (2013) on the 
different non-pharmacologic 
treatments for ADHD 
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Benjamin F Feingold MD 
(1899, 1982) was a US 
pediatrician who proposed 
that salicylates and food 
additives, such as artificial 
colors and artificial flavors, 
cause hyperactivity in 
children. Eliminating these 
foods (Feingold diet) would 
be expected to reduce 
hyperactivity.
Table D.1.1.1 Preservatives to be eliminated from the diet (www.feingold.
com)
ABBREVIATION NAME E-NUMBER*
BHA Butylated hydroxyanisole E 320
BHT Butylated hydroxytoluene E 131
TBHQ Tertiary butylhydroquinone E 319
*Codes for substances that are permitted as food additives within the 
European Union and Switzerland (see Box).
THE INTERNATIONAL NUMBERING SYSTEM FOR FOOD ADDITIVES 
(INS)
This is a European-based naming system for food additives aimed at 
providing a short designation for what may be a lengthy chemical name. 
It is defined by the Codex Alimentarius of the international food standards 
organization. The information is published in the document “Class Names 
and the International Numbering System for Food Additives”. The INS is 
an open list, subject to the inclusion of additional additives or removal of 
existing ones. INS numbers consist of three or four digits. Approved food 
additives are written with a prefix of E on food packaging in the European 
Union. Australia and New Zealand do not use a prefix letter. INS numbers 
generally correspond to E numbers for the same compound, e.g. INS 102 
(tartrazine), is also E102. INS numbers are not unique and, in fact, one 
number may be assigned to a group of similar compounds. The US does not 
use the INS numbering system (Wikipedia).
Clinical  Implications
Despite the long-standing controversy on the effects of food colors and 
preservatives on ADHD symptoms, the evidence available still has many gaps. 
Most if not all studies are of small size, the mechanisms and predictors of response 
are unknown, and it is unclear which chemicals and at which dose have a clinical 
impact. Nevertheless, the effect size on ADHD symptoms of exclusion diets is 
small, not large enough to justify it being recommended as stand-alone treatment. 
It may be a useful adjunctive treatment for some cases. 
Decisions to explore the clinical utility of such diets in individual cases 
should be weighed against difficulty and expense (e.g., it is hard to implement in 
a household with several children, requires intrusive monitoring of compliance 
that in itself could impact negatively on the parent-child relationship, and it is 
expensive to source additive-free foodstuffs).
Future Directions
• There is a need for rigorous large-scale studies on the effects of food 
colors and preservatives on ADHD symptoms and related behaviors 
such as aggression, oppositionality and emotional lability
• Though the effect size of food exclusion diets is small from a clinical 
perspective, it may be substantial from a population-wide, health care, 
and food policy perspectives. The prevention paradox states that most 
cases derive from low-risk individuals and that a rather small protective 
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effect on the wider population could reduce caseness more often than 
an intervention targeting clinical cases or high-risk individuals (Rose, 
1981)
RESTRICTIVE ELIMINATION OR OLIGOANTIGENIC DIETS
Adverse physical reactions (e.g., eczema, asthma, allergic rhinitis, and 
gastrointestinal problems) to some foods have led to the hypothesis that specific 
foods might also have an impact on the brain, resulting in adverse behavioral 
effects. In oligoantigenic diets the focus is on foods other than artificial colors and 
preservatives that may trigger ADHD symptoms in some children by acting as 
food antigens or allergens. Foods often found to be allergenic include cow’s milk, 
cheese, eggs, chocolate, and nuts. Thus, an individually constructed oligoantigenic 
or restricted elimination diet might be an effective treatment for ADHD (Nigg et 
al, 2012; Pelsser et al, 2011). 
A typical food allergy is a reaction to foods involving specific antibodies 
(e.g., IgE). It has been hypothesized that in non-IgE-mediated reactions to food, 
determination of IgG may be a helpful adjunct, and IgG blood tests are widely 
offered to establish a relationship between foods and ADHD symptoms, especially 
in complementary medicine settings. According to the IgG-ADHD theory, foods 
associated with high IgG-levels would result in a significant behavioral deterioration 
when eating these foods, while foods associated with low IgG-levels would not. 
However, evidence of the value of these tests is lacking. Further, in a restricted 
elimination study, worsening of ADHD symptoms occurred independently of 
IgG levels of the challenging foods, thus questioning the role of IgG-mediated 
mechanisms (Pelsser et al, 2011). 
Treatment Delivery and Available Treatments
Restrictive elimination diet interventions typically involve a temporary (2-5 
weeks) total change of diet, in which the child is only allowed to consume a few 
hypo-allergenic foods (e.g., rice, turkey, lettuce, pears, and water). If it results in 
a substantial decrease in ADHD symptoms (i.e., it shows to be “food sensitive”), 
a 12-18 month reintroduction phase is conducted to find out which specific 
foodstuffs trigger ADHD symptoms. The rationale is that a person may show 
adverse reactions to a variety of foods and that it is important to determine the 
individual’s susceptibility to the specific foods that cause the adverse reactions. 
Effectiveness
A meta-analysis reported an effect size of 0.29 across 6 controlled trials 
including 195 participants and concluded that about one third of the children 
with ADHD show an excellent (>40% symptom reduction) response (Nigg et al, 
2012). Another meta-analysis estimated an effect size of 1.48 for the most proximal 
assessment (by the person applying the treatment). However, effect size dropped to 
0.51 when probably blind raters were used (Sonuga-Barke et al, 2013). There was 
considerable heterogeneity across studies due to different designs and on how strict 
was the food elimination. Studies included a small number of participants. There 
are no studies reporting medium to long-term effectiveness and cost-effectiveness.
ANTIBODIES
Antibodies are formed from 
short light chains (with low 
molecular weight) and long 
heavy chains (with high 
molecular weight). Of these, 
there are five types of heavy 
chains, and the type of 
antibody is determined by 
differences in these heavy 
chains (IgG, IgM, IgA, IgD, 
IgE). 
IgE is believed to be related 
to immunity reactions to 
parasites and has recently 
become known as a key 
factor in allergies such as 
hay fever.
IgG is the main antibody 
in the blood. It is the 
only one that can pass 
through the placenta, and 
IgG transferred from the 
mother’s body protects 
a newborn until a week 
after birth. IgG is widely 
distributed in the blood and 
tissues, and protects the 
body.
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Clinical Considerations
• A strictly supervised elimination diet is a valuable approach to assess 
whether ADHD in a given child might be food-sensitive. As IgG blood 
tests do not provide information about which foods might provoke 
ADHD symptoms, the prescription of diets based on these tests should 
be discouraged
• Children with ADHD and their parents who are interested in 
elimination diets need to be supervised closely because adherence to 
the diet requires efforts and motivation by the whole family
• Implementation of this diet requires a drastic  change of lifestyle; 
success will depend on the family’s organizational skills and parents’ 
level of control over the child’s diet
Future Directions
• Large scale, multisite clinical trials into the feasibility, effectiveness and 
cost-effectiveness of elimination diets for children with ADHD are 
needed. These studies should aim to identify predictors of response 
and establish the long-term effectiveness
• Future research might also need to target the gut microbiota/brain 
connection as a potential mechanism underlying the effects of 
elimination diets
SUPPLEMENTATION WITH OMEGA-3 AND OMEGA-6 FATTY 
ACIDS
Around 25-30% of all fatty acids in the brain are polyunsaturated. They 
play an important role in the structure and function of neuronal cell membranes 
in the brain, retina and myelin sheath. Two fatty acids, also called “essential”, 
α-linolenic (an omega-3 fatty acid) and linoleic (an omega-6 fatty acid) cannot be 
synthesized by humans and need to be acquired through the ingestion of foods (see 
Figure D.1.1.1). Whereas α-linolenic is sparsely distributed in soybean, canola, 
and flax seeds oil, linoleic acid is more abundant; over 50% of all fatty acids in 
soybeans, corn and sunflower oil is linoleic. Omega-6 and omega-3 fatty acids are 
not interchangeable; the former have anti-inflammatory properties, whereas the 
latter is pro-inflammatory.
Several studies have reported lower concentrations of omega-3 fatty acids 
in plasma and erythrocyte membranes in children and adults with ADHD 
(Bloch 2011). Abnormally low essential fatty acids in children with ADHD 
may be due to reduced intake, reduced conversion of essential fatty acids to 
long chain polyunsaturated fatty acids, and increased metabolism of long chain 
polyunsaturated fatty acids, but  none of these  alternatives have been properly 
studied (Millichap et al, 2012). 
Treatment Delivery and Available Treatments
There are numerous commercial products (gels, capsules, and liquids) available 
to  supplement omega-3 fatty acids in the diet. Most supply eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA) (see Figure D.1.1.1) in amounts that vary 
up to ten-fold. Additionally, many products also contain other micronutrients or 
vitamins hypothesized to be deficient in patients with behavior disorders. 
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Figure D.1.1.1 Fatty-acid synthesis pathway
Effectiveness
Two meta-analyses concluded that supplementation  with these fatty acids 
was associated with a small but reliable reduction of ADHD symptoms, with effect 
sizes ranging from 0.18 to 0.31 (Sonuga-Barke et al, 2013; Bloch, 2011). Higher 
doses of omega-3 supplements were significantly associated with a larger reduction 
of ADHD symptoms (Bloch, 2012). A third meta-analysis did not find statistically 
significant differences on parent and teacher ratings of ADHD symptoms between 
fatty acids supplementation and placebo (Gilles et al, 2012). None of the studies 
monitored plasma levels of free fatty acids. This and other methodological 
limitations should lead to caution when interpreting the significance of these 
effects. There are no studies on the long-term effectiveness and cost-effectiveness. 
Clinical Considerations
• The clinical relevance of fatty acid supplementation in treating ADHD 
remains unclear. Some researchers have suggested that fatty acid 
supplements be considered as an add-on treatment in children who 
show partial response to medication. If so, the recommended doses are 
300 to 600 mg/day of omega-3 and 30-60 mg/day of omega-6 fatty 
acids for at least 2 or 3 months, or longer if indicated (Millichap et al, 
2012). Given the low effect sizes, it is important to monitor carefully 
whether supplements have any benefit and to continue using them 
only if this is the case
• Side effects are minor and include fishy taste and odor, stomach upset, 
loose stools, and nausea. 
Future Directions
• There is a need for high-quality, large sample, controlled studies with 
fatty acid supplementation that include patients with different ages 
(preschoolers, school age children and adolescents) and monitor the 
plasma levels of fatty acids at baseline and during treatment.
SUPPLEMENTATION WITH MICRO-NUTRIENTS
Neurotransmitter metabolism requires enzymes, and enzyme function 
is dependent upon the presence of adequate quantities of multiple coenzymes 
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(cofactors), such as vitamins and minerals. Conditions such as ADHD and other 
psychiatric disorders may be associated with metabolic dysfunctions that limit 
the availability of vitamin and mineral cofactors and results in slowed metabolic 
activity (Kaplan et al, 2007; Ames et al, 2002).  This may be remediated by 
supplementation with micronutrients. Deficiencies of micronutrients may play a 
role in the cognitive deficits associated with ADHD (Mikirova et al, 2013; Sarris 
et al, 2011; Scassellatti et al, 2012). Further, outside the context of ADHD, the 
quality of the nutrition in the first years of life is associated with children’s later 
cognitive and academic abilities (Nyaradi et al, 2013; Prado & Dewey, 2014).
Treatment Delivery and Available Treatments
There is a multitude of commercially available products that follow a 
“broad spectrum approach” by providing multi-ingredient and/or multivitamin 
supplementation and claim effectiveness in reducing symptoms of ADHD 
and other psychiatric conditions such as bipolar illness, anxiety disorders, and 
depression. 
Effectiveness
Micronutrient treatment trials vary but for the most part have focused on single 
nutrients such as iron, magnesium and zinc. They have demonstrated modest to 
negligible effects (Cortese et al, 2012; Ghanizadeh et al, 2013; Rucklidge et 
al, 2009). A well-designed, blinded, randomized clinical trial has shown large 
improvements in ADHD symptoms in adults after a broad spectrum vitamin-
mineral treatment (Rucklidge et al, 2014). An open label pilot trial using the 
same micronutrient formula in 14 children with ADHD reported significant 
improvement in parent reported ADHD symptoms (Gordon et al, 2015).  
Clinical Considerations
• Dose and variety of ingredients in micronutrient supplementation may 
be important in effecting change in ADHD, but no specific guidance 
can be given since data are lacking 
• Current studies did not raise safety issues, but very high doses can 
become toxic with no associated benefit as demonstrated by earlier 
studies that gave mega doses (Arnold et al, 1978)
Future Directions
• Good quality, large controlled studies with micronutrient 
supplementation that include patient with different age ranges are 
needed
• These studies should be combined with biochemical assessments to 
probe for real deficiencies and to examine the combined effects of 
micronutrient supplementation with other dietary interventions
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PSYCHOSOCIAL TREATMENTS
BEHAVIORAL INTERVENTIONS 
Psychosocial treatments based on social learning and behavior modification 
principles have been widely used, often through parent training-based approaches. 
Behavioral interventions can be defined broadly as therapies using learning 
principles to target ADHD or ADHD-related behaviors (Sonuga-Barke et al, 
2013). 
Behaviorally focused treatments can be delivered by therapists, parents, or 
by other “facilitators” (for example teachers). Facilitators are taught to use basic 
operant conditioning principles—behavior is modified though positive (e.g., 
praise) and negative (e.g., ignoring inappropriate behavior) reinforcement—to 
shape more appropriate behavior in the child; this is also called “contingency 
management”. 
A daily report card is an example of a tool based on operant learning 
principles;  teachers reinforce appropriate behaviors daily by giving feedback (for 
example by  sticking stars or “smilies” on the  report card) for appropriate behaviors 
in the school. Moreover, this tool can go between home and school facilitating 
interaction and communication between parents and teachers (see Figure D.1.1.2). 
Another objective of these behavior-focused treatments is to reduce 
maladaptive behavior. To achieve this, parents and teachers are trained to use a 
more structured approach when dealing with a child with ADHD about everyday 
issues—for example, by giving clear instructions, one instruction at a time, or by 
providing in the morning a clear and realistic  plan for the day—so  that children 
know what is expected of them. Finally, an important aspect of these treatments 
is to enhance enjoyable parenting and positive interactions between parent and 
child, as a negative coercive cycle between parent and child often develops (Van der 
Oord & Daley, 2015). These interventions are typically used for pre-school and 
primary school-aged children rather than for adolescents. 
Skills-based interventions assume that individuals with ADHD have core 
deficits in certain skills (e.g., planning and organization) and seek to enhance these 
skills either directly with the individual or through parents and teachers (Evans et 
al, 2014). These interventions can be provided in the clinic (Abikoff et al, 2015; 
Boyer et al, 2015) or the school, mainly through after school programs (Evans et 
al, 2016) that focus on enhancing skills such as planning, organization, and social 
Figure D.1.1.2 Example of a daily report card
Click here for advice to 
teachers on how to design 
daily report cards 
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interaction.  Skills based interventions are useful for both school-age children and 
adolescents. 
Cognitive interventions for ADHD may also target children’s negative 
schemas or thoughts, based on the premise that thoughts, feelings and behaviors 
are interrelated and that changing one element of this triad will modify the others 
(Antshel & Olszewski, 2014). They are typically delivered individually and are 
particularly useful for adolescents.
Treatment Delivery and Available Treatments
Should behavioral treatments be provided in a group or individually, at 
home, at school, or in a mental health service? Are there lower-cost alternatives 
such as self-help interventions that are effective? 
Parent training 
The National Institute for Health and Clinical Excellence (2008) of the 
UK recommends group behaviorally-focused parent training interventions (see 
Chapter A.12 of the Textbook). These interventions are effective for children with, 
or at risk of, ADHD (Webster-Stratton et al, 2011; Jones et al, 2007), but there is 
no evidence to suggest that group is more effective than individual intervention. 
Parents of children with ADHD often display symptoms of ADHD 
themselves and may struggle with the organizational challenges of attending 
group-based sessions in clinic or community settings. To enhance effectiveness, 
treatments should be adapted to the needs of the target group, and be provided 
in the setting where maladaptive behavior is manifested (Kazdin & Blase, 2011). 
An unpublished study by Sonuga-Barke et al compared the relative efficacy of 
an individual home-based parenting program for ADHD (New Forest Parenting 
Program) with a group-based parenting intervention run in the community 
(Incredible Years), and with treatment as usual for a large group of hard to engage 
and difficult to treat parents of preschool children at risk of ADHD. Results 
suggested no clear advantage of the home based intervention in terms of symptom 
severity, but the individual intervention was more cost effective. However, the 
individual home-based intervention was preferred by parents (see Wymbs et al, 
2015 for a discussion of parents’ treatment preferences). 
School-based interventions
School-based interventions are very diverse and it is a challenge to reach 
general conclusions. Not all school-based treatments aim at reducing ADHD 
symptoms specifically, some seek to deal with the academic problems commonly 
shown by children with ADHD. 
Specific manipulation of academic instructions and materials can have a 
positive effect on ADHD children’s learning efficiency  (e.g., sitting closer to the 
teacher, providing shorter assignments, note-taking training, assisted oral reading, 
structured schedules and rules, alternating easier with more difficult exercises, 
allowing regular breaks, intra-task stimulation by adding colors or highly engaging 
stimuli) (Raggi & Chronis, 2006; Schultz et al, 2011). Peer tutoring (i.e., paring 
an ADHD pupil with a highly achieving, supportive student) (DuPaul et al, 1998), 
as well as computer enhanced learning, applying a multi-sensory approach and 
Click on the image to access 
a video on parent and 
teacher training for ADHD
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immediate feedback (Clarfield & Stoner, 2005; Ota & DuPaul, 2002) have shown 
beneficial effects but have not been studied in controlled designs. 
A review of research conducted over 32 years has identified more than 
50 studies (including 36 randomized controlled trials) of non-pharmacological 
interventions in school settings addressing ADHD symptoms (Richardson et al, 
2015). The majority targeted children at elementary/primary school level.  Four 
categories of interventions were defined based on common ingredients: 
1. Reward and punishment (contingency management)
2. Skills training and self-management
3. Creativity-based therapies and 
4. Physical treatments
Contingency management  has been studied the most, followed by academic 
skills training, emotional skills training, self-regulation, biofeedback, daily report 
card, social skills training, cognitive skills training, adaptation to the learning 
environment, music therapy, motivational beliefs, psychoeducation, play therapy, 
and massage. A large proportion of the interventions was delivered by teachers 
within the classroom but often mental health providers were involved. The length 
of the intervention varied widely (between 1 and 156 weeks, with a mean of 15.5 
weeks). Across all these different interventions there was some beneficial effect on 
inattention and hyperactivity/impulsivity assessed with neurocognitive tasks and 
on teacher-rated inattention (Richardson et al, 2015). However, there was little 
effect according to parent-observed ADHD symptoms. There was a small effect on 
Figure D.1.1.3 Summary of recommended behavioral interventions for ADHD 
throughout the lifespan*
*M Ferrin, with permission.
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standardized achievement tests and on teacher reported externalizing symptoms. 
Effectiveness of Behavioral Interventions 
Two meta-analyses explored the short-term effectiveness of behavioral 
interventions (broadly defined) compared to control conditions (Sonuga-Barke et 
al, 2013; Daley et al, 2014). Results were presented separately for outcomes that 
may be biased towards favorable reporting because of involvement in the treatment 
(e.g., parent ratings), and for other outcomes that could represent more objective 
Figure D.1.1.4 Child and parents outcomes of behavioural 
interventions in ADHD acording to informant.*  MPROX is based on reports 
by individuals who may be biased towards favorable reporting because of 
involvement in the treatment (e.g., parent ratings); PBLIND is based on 
more objective measures (e.g., teacher ratings). Low Meds represents the 
results of studies with less than 30% of the children in the sample receiving 
medication.
*With permission from Daley et al 
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measures (e.g., teacher ratings). Results (see Figure D.1.1.4) showed a significant 
improvement in ADHD symptoms when reports from the person applying the 
treatment were considered (“most proximal”), but there was no change according 
to the more objective informants (“probably blind”). However, both groups of 
informants reported a significant benefit in relation to conduct problems, positive 
parenting, and for reduction in negative parenting.  Significant effects were also 
found on social skills and academic performance; however, blinded outcomes 
were not available for these variables.  Finally, no impact was found on parental 
wellbeing. 
Studies exploring the long-term efficacy of behavioral interventions are 
sparse and typically they are naturalistic follow-ups where other treatments (e.g., 
medication) are often used concurrently. Therefore it is difficult to disentangle 
the specific long-term effects of the behavioral interventions. For parent training, 
positive effects on parenting behavior and parent reports of child’s behavior are 
maintained for up to 3 months to 3 years after treatment, depending on the study 
(Lee et al, 2012).
Clinical Considerations
• According to most studies, children with comorbid ODD/CD 
and comorbid anxiety disorders are the most likely to benefit 
from behavioral interventions
• Larger effect sizes were observed in preschoolers and in children 
not taking medication (Daley et al, 2014)
• Lower parental education, greater parental mental health 
problems and greater child complexity and comorbidity are likely 
to be related to worse outcomes (Daley & O’Brien, 2013)
• A challenge for behavioral approaches has been to generalize the 
benefits from the treatment setting to other settings
• Since some reliable effects have been shown on relatively 
objective measures of neurocognitive assessments and academic 
achievement, these offer some support for the effectiveness of 
non-drug treatment in school settings. Because many different 
intervention packages or combinations are used, it is impossible 
to identify the potentially active ingredients 
• Barriers are that these treatments are expensive, both in terms of 
time and money, and parents need to be motivated 
• Evidence supports the efficacy of educational interventions 
with parents (Ferrin et al, 2014; Ferrin et al, 2016) and of self-
help interventions either on their own or in combination with 
telephone or media support (Sanders et al, 2007). According to a 
Cochrane review (Montgomery et al, 2006) self-help interventions 
can: (i) reduce the amount of time therapists have to devote to 
each case; (ii) increase access to the intervention; (iii) release 
clinician time to concentrate on more complex cases; (iv) reduce 
or eliminate costs, transport and timing difficulties for families.
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Future Directions
• More evidence from blind studies is required before behavioral 
interventions can be supported as a first-line treatment for core ADHD 
symptoms
• Despite the many randomized controlled trials assessing school 
interventions in ADHD—which already show a large improvement 
when compared with earlier reviews (DuPaul et al, 1998)—there is a 
need for better designed studies (Richardson et al, 2015)
• Self-help approaches may work best within a stepped care clinical 
model, with self-help targeted at parents who are waiting to access face-
to-face treatment. Also, self-help could be used in combination with 
face-to-face treatment or on a triage basis. It could be offered as an 
initial intervention that may be enough for some highly functioning 
parents or those with children with less complex problems
• More research is needed on how to engage parents in self-help 
interventions and to clarify who may benefit the most
COGNITIVE TRAINING 
ADHD is associated with a broad range of neuropsychological impairments 
encompassing multiple brain networks known to underpin diverse cognitive and 
motivational processes (Willcutt et al, 2008). There has been an increasing interest 
in, and use of, computer-based cognitive training as a treatment for ADHD 
with different approaches used to target different neuropsychological deficits 
(i.e., working memory, attention, inhibition). Cognitive training is grounded 
on the notion of neural plasticity and the reorganization of brain structure and 
function in patients experiencing lesion-based deficits and cognitive impairments 
(Jolles & Crone, 2012; Willis & Schaie, 2009). Models rely on the assumptions 
that particular neuropsychological deficits mediate ADHD pathogenesis, and 
that repeatedly loading a limited cognitive resource would eventually lead to its 
strengthening and improved functioning.  However, specific neurobiologic models 
of the effects of cognitive training strategies used with ADHD patients are lacking.
Treatment Delivery and Available Treatments
Cognitive training for ADHD is typically delivered using computers. 
Training sessions may be conducted at school, home, or in the clinic. The duration 
of each session, number, and frequency vary according to the specific protocol 
employed—they typically involve a large number of sessions spread over several 
weeks. The difficulty level is automatically adjusted by the software on a session by 
session basis to match the improving working memory of the subject on each task, 
to drive learners to increasingly higher levels of performance as training proceeds. 
This includes an individualized reward schedule. Table D.1.1.2 lists commonly 
used, computerized cognitive training programs.  
Effectiveness
The first controlled trial that examined the benefits of cognitive training for 
ADHD was reported by Klingberg and colleagues (2005). They reported a large 
positive effect on parent ratings of ADHD but this did not generalize to teacher 
Click on the image to view 
an example of how Cogmed, 
one of the cognitive training 
programs, is supposed to 
work.
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Table D.1.1.2. Commonly used computer-based cognitive training programs* 
PROGRAM TARGET FUNCTION
AixTent (CogniPlus) Attention: selective, divided, focused and 
constant
Captain’s Log Attention, working memory, visuomotor 
function, problem solving
Cogmed (RoboMemo) Visuospatial and spatial-verbal working 
memory
CogniPlus Attention, working memory, visuomotor 
function, executive functions, long-term 
memory
Locu Tour Acoustic, visual, and verbal attention, 
executive functions, acoustic and visual 
memory
Play Attention Attention
RehaCom Attention, memory, executive functions, 
visuomotor functions
Braingame Brian (in Dutch) Training working memory, inhibition and 
flexibility 
*Adapted from Sonuga-Barke et al, 2014. Click on the name of the program 
to access.
ratings. The meta-analysis by Sonuga-Barke et al (2013) reported data from 126 
participants and 123 controls. Overall, there was a moderate and significant effect 
in favor of the intervention by the end of treatment. However, the effect dropped 
substantially and became not significant when ratings by (probably) blind raters 
were considered. Similar results were reported in another meta-analysis (Cortese 
et al, 2015).
Clinical Considerations 
• There is no definitive evidence of the effectiveness of cognitive training 
in ADHD 
• Cognitive training may improve working memory, however the impact 
on academic functioning is not yet determined (Cortese et al, 2015)
• Contraindications and side effect of these treatments are not well 
known
Future Directions
• Approaches targeting multiple neuropsychological processes may 
optimize the transfer of effects from cognitive deficits to clinical 
symptoms, but this requires further research
• There is a particular need for studies examining the relative value 
of combining cognitive training with medication, dietary, or other 
psychological approaches (Vinogradov et al, 2012)
• Future research should explore whether cognitive training may also 
play a role in early intervention approaches for ADHD
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• Trials in the future need to compare the response of clinical subtypes 
and neuropsychological sub-groups to different forms of training. 
NEUROFEEDBACK 
Neurofeedback has been seen as a promising treatment for core ADHD 
symptoms based on the results of some controlled studies (Arns et al, 2009). The 
increasing acceptance of neurofeedback as a treatment for ADHD derives from 
observations of altered brain activation in many children with ADHD detected 
in EEG and imaging studies. Neurofeedback is based on the principle that the 
types of waves registered by EEG represent different psychological states, e.g., 
whether the individual is concentrating in an activity or distracted, day-dreaming. 
By giving real time information about the type of wave observed at any given time 
and rewards, children can be taught to produce the brain-wave pattern associated 
with concentrating on a task. This would reduce symptoms of ADHD.
Two different protocols for treatment are available to address deviant cortical 
activity in ADHD children: 
• EEG frequency band training, which seeks to reduce slow wave activity 
and increase faster (alpha wave) activity
• Event-related cortical potentials training.  Event-related potentials allow 
the examination of electrical responses reflecting preparatory and pre-
attentive processes, auditory and visual attention, frontal inhibition, 
and time processing. A lower amplitude, longer latency and different 
topography of the P300 component has been the most replicated finding 
in ADHD children when compared to healthy controls (Brandeis et al, 
2002).The characteristics of P300 and other components of the evoked 
potentials have been used for neurofeedback. 
Treatment Delivery and Available Treatments
A conventional neurofeedback protocol to reduce inattention and impulsivity 
consists of rewarding the suppression of theta activity and enhancement of beta 
activity. Using visual feedback, the trainee receives a large amount of rewards 
throughout the training. In some programs, the cortical activity is represented 
by the height or speed of an object, such as a ball, a plane, or a cartoon character 
moving across the screen. If the EEG activity is regulated in the desired way, the 
object rises, falls, or advances more quickly. In other animations, the patient is 
asked to view a movie, or change the color of an object in the screen by generating 
the target brain wave activity. Successful trials are immediately rewarded by a tone, 
a smiley face, coins, or points. Individual parameters are adjusted throughout the 
course of the training to ensure positive feedback in some trials, while other trials 
operate without feedback in order to extend the results to the everyday life of the 
patient. 
Effectiveness 
Several controlled studies support the short-term improvement in core 
symptoms, neuropsychological function, and electrophysiological correlates of 
ADHD achieved with neurofeedback (Gevensleven et al, 2012;  Fabiano et al, 
2009; Nigg et al, 2012; Sonuga-Barke et al, 2013; Micoulaud-Franchi et al, 2014). 
However, a more recent meta-analysis has found no reduction in core symptoms 
Click on the image to view 
Dr Selim R. Benbadis talking 
about whether ADHD can 
really be diagnosed by EEG?
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ELECTROENCEPHALOGRAM (EEG)
Electroencephalogram refers to the recording of brain electrical activity. It is 
typically obtained by placing electrodes on the scalp, not very differently from 
those used to obtain electrocardiograms. EEG measures voltage fluctuations 
resulting from electrical currents in brain regions, not in individual neurons. 
Related techniques are evoked potentials or event-related potentials, 
which measure stereotyped electrical brain responses to specific sensory, 
cognitive, or motor stimuli. Evoked potentials are obtained by averaging EEG 
activity triggered by the presentation of a stimulus (visual, somatosensory, or 
auditory). 
Five frequency bands have been traditionally defined in EEG recordings:  
delta (1.5–3.5 Hz), theta (3.5–7.5 Hz), alpha (7.5-12.5 Hz), beta (12.5-30 
Hz), and gamma (30-70 Hz). The type of brain activity recorded depends 
on many factors, e.g., whether persons are awake or in different stages of 
sleep, what they are doing, and if their eyes are open or closed. 
Quantitative EEG (qEEG)—also called brain mapping and brain electrical 
activity mapping (BEAM)—is a method of analyzing the electrical 
activity of the brain to show a topographic display and analysis of brain 
electrophysiological data. The clinical significance of the various patterns 
of brain wave activity is unknown and the value of quantitative EEG in 
diagnosis and treatment of ADHD and other conditions has not been 
demonstrated unequivocally.
EEG in children differs from adult EEG because of developmental 
maturation—lower frequency bands are most prominent during the first 
years of life, decreasing with increasing age. A substantial group of ADHD 
children have shown elevated levels of slow wave (delta and theta) activity in 
the frontal regions. An increase in the theta/alpha and theta/beta ratios have 
been claimed to be reliable measures of the presence of ADHD (Monastra et 
al, 1999). However, this has low specificity and the usefulness of the theta/
beta ratio as a specific marker for ADHD has been questioned.
P300
The P300 wave (P3 in 
the figure below) of an 
event related potential has 
received particular attention 
in relation to ADHD. P300 
is a positive wave complex 
that occurs about 300-
500 milliseconds after the 
stimulus. It is obtained when 
the individual’s attention 
is focused on a signal that 
is rare, especially if the 
signal has a motivational or 
emotional meaning. P300 is 
thought to reflect processes 
involved in stimulus 
evaluation or categorization. 
It is typically elicited using 
the “oddball paradigm”, 
in which low-probability 
stimuli are mixed with 
high-probability non-target 
(or standard) items. For 
example, in a visual oddball 
task, a square (standard) 
is presented 95% of the 
time and a circle (oddball) 
5%. When the targets (e.g., 
circles) appear, the subject 
must make a response, 
such as pressing a button 
or updating a mental count. 
The characteristics of the 
P300 wave in this situation 
are often used as measures 
of cognitive function in 
decision making. 
FIGURE D.1.1.5 The picture describes the brain-computer interface 
architecture sequence: brain activity monitoring, translation into commands, 
electrophysiological signals, commands subject and action feedback.
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or in any neuropsychological outcomes explored (e.g., inattention and response 
inhibition) (Cortese et al, in press).  Results are difficult to interpret because of 
the weak experimental design of many studies (e.g., lack of controls, non-random 
allocation, or the use of non-blind measures). No differences were observed 
when using quantitative EEG or evoked potentials as the basis for biofeedback 
(Gevensleven et al, 2009). Trials that compared neurofeedback with medication 
alone or in combination reported conflicting results (Duric et al, 2012; Meisel et 
al, 2013; Li et al, 2013; Ogrim et al, 2013). 
Clinical Considerations 
• A number of factors might contribute to clinical response, including 
training intensity and number of sessions; visual imagery of the 
individual; parenting style; use of reinforcement techniques at home; 
and motivation (effort, attention, and time invested)
• Epilepsy might be a contraindication
• Potential side effects include headaches and fatigue
Future directions
• The question whether one training protocol is more effective than the 
other is not yet resolved (Holtmann et al. 2014).
• Techniques such as near-infrared spectroscopy and fMRI neurofeedback 
may offer advantages in terms of targeting well defined brain regions 
(Mihara et al, 2012). Notably, real time fMRI may additionally open 
the possibility of more rapid learning to regulate deep structures such 
as dopaminergic midbrain regions implicated in ADHD (Cortese et 
al, 2012).
Click on the image to view 
how neurofeedback works in 
practice
Ma Haifang. Children at school.
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Appendix D.1.1.1
SELF-DIRECTED LEARNING EXERCISES AND SELF-ASSESSMENT
MCQ D.1.1.1  Restrictive elimination diets for 
ADHD: 
A. Have been shown to be an effective 
treatment
B. Have a small effect size on ADHD 
symptoms, not large enough to justify 
recommending it as a stand-alone 
treatment
C. Are only effective in adolescents
D. Are effective on comorbid depressive 
symptoms
E. Are simple and cheap to implement
MCQ D.1.1.2  Oligoantigenic diets focus 
on foods other than artificial colors and 
preservatives that may trigger ADHD 
symptoms. Implementation of these diets:
A. Requires all the family to be on the diet
B. Do not show results for at least 6 months
C. Usually excludes cow’s milk, cheese, 
egg, chocolate, rice and nuts
D. Should be tried in all cases
E. Is very effective
MCQ D.1.1.3 Fatty-acid supplementation for 
ADHD:
A. Has significant side effects
B. Requires supplementation with omega-3 
fatty acids only
C. Requires supplementation with omega-6 
fatty acids only
D. Requires supplementation with both 
omega-3 and omega-6 fatty acids
E. Has been found to be ineffective
MCQ D.1.1.4  Psychosocial treatments 
based on social learning and behavior 
modification principles have been widely 
used for ADHD. The intervention most widely 
supported by evidence for younger children is:
A. Contingency management
B. Skills training 
C. Creativity-based therapies
D. Self-management
E. Parent  training programs
MCQ D.1.1.5  Children most likely to 
benefit from behavioral interventions are those 
who:
A. Come from lower socio-economic status 
families 
B. Have parents with mental health 
problems
C. Have comorbid ODD/CD
D. Are older (e.g., adolescents)
E. Have higher levels of family conflict
MCQ D.1.1.6  A form of neurofeedback is 
called EEG frequency band training. This 
intervention seeks to:
A. Reduce slow wave activity and increase 
faster (alpha wave) activity
B. Modify event-related cortical potentials
C. Help the child control epileptiform EEG 
activity
D. Induce brain maturation
E. Increase neuronal metabolism
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ANSWERS
MCQ D.1.1.1  Answer: B
MCQ D.1.1.2  Answer: C
MCQ D.1.1.3  Answer: D
MCQ D.1.1.4  Answer: E
MCQ D.1.1.5  Answer: C
MCQ D.1.1.6  Answer: A
